PRNewswire

ELK GROVE VILLAGE, Ill., Nov. 25, 2024 /PRNewswire/ — Orsini is now distributing BridgeBio’s ATTRUBY™ (acoramidis), an orally administered treatment for cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM). ATTRUBY is a near-complete (≥90%) stabilizer o

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: